Australian Life Sciences Stock News

Ionic Rare Earths’ grant-backed recycling plans could give this ASX rare earths stock a clearer test of its China-free supply chain thesis.

Energy shocks, war headlines and interest rate uncertainty are back at the center of markets, with Brent crude recently surging over 50% and central banks warning about future supply and inflation risks. When oil, inflation and rates move together, some stocks can benefit from higher pricing power or stronger demand, while others face rising costs or pressure on funding. This article looks at 3 stocks exposed to the current Iran war and rate backdrop, including 2 that may gain from these...

Artificial intelligence in healthcare sits at the crossroads of rising global cost pressures, tighter monetary policy debates, and consumers who still want better treatment and access. While inflation, rates, and commodity shocks keep moving the macro picture, AI-driven diagnostics, remote care, and research tools target long term efficiency gains and more accurate care. The Transformative AI Healthcare Stocks screener focuses on companies using AI to improve diagnostics, personalise...

Recent attention on Lovisa Holdings (ASX:LOV) centres on its international store expansion, brand development and operational execution, as investors evaluate how these efforts relate to comparable sales and the stock’s recent price move. See our latest analysis for Lovisa Holdings. Lovisa Holdings’ recent 11.01% 1 month share price gain contrasts with a year to date share price decline of 22.57% and a 1 year total shareholder return decline of 23.89%, while 3 and 5 year total shareholder...

Automation pressure at Australian ports is turning into a real test for companies tied to global trade. Dock workers pushing for a 28 hour week with full pay, rising AI adoption and the risk of strikes or disruptions can all feed into higher costs, operational hiccups and changing sentiment around logistics exposed stocks. For investors, this is less about headlines and more about understanding which businesses are most directly exposed to the news and where labor, regulatory and technology...

With inflation signals mixed across regions and interest rate expectations constantly reassessed, many investors are turning to dividend powerhouses for more predictable income. The Dividend Powerhouses (3%+ Yield) screener focuses on companies paying more than a 5% yield that appears well covered, growing and stable, which can be especially appealing when bond markets and central bank policy paths feel hard to read. Instead of trying to time every macro twist, you can focus on cash flows...

Australian shares are expected to open lower today, influenced by recent geopolitical tensions in the Middle East and a decline in U.S. semiconductor stocks. In such fluctuating market conditions, investors often look beyond well-known names to discover opportunities among smaller or newer companies. Although the term "penny stock" might seem outdated, these investments can still offer substantial value when backed by solid financials and potential for growth.

Insiders who bought AU$1.47m worth of OpenLearning Limited ( ASX:OLL ) stock in the last year have seen some of their...

Penny stocks often carry a reputation for high risk, but the Financially Fit Penny Stocks screener targets a narrower corner of this space, focusing on companies trading below 5 that also show signs of solid financial health. With investors watching inflation pressures, interest rate expectations and mixed growth signals across major economies, balance sheet strength and funding resilience matter more than ever. This screener aims to filter for those qualities so you can focus on potential...

Insiders who purchased AU$3.43m worth of DigitalX Limited ( ASX:DCC ) shares over the past year recouped some of their...

Betmakers Technology Group Ltd ( ASX:BET ), might not be a large cap stock, but it saw a double-digit share price rise...

With inflation trends, interest rate expectations and energy prices all pulling markets in different directions, many investors are looking for opportunities where cash flows and valuation still line up in a sensible way. The Undervalued Stocks Based On Cash Flows screener focuses on companies that SWS DCF valuation suggests are trading below fair value, which can appeal if you care about what a business earns in cash rather than headlines. In this article, you will see 3 stocks from this...

Earlier this month, Commonwealth Bank of Australia outlined a slower domestic economic outlook, with its economists projecting A$ GDP growth of about 1.5% in 2026 as softer housing markets and steady interest rates weigh on household spending. At the same time, CBA’s status as Australia’s largest listed bank and a core bluechip is drawing renewed attention as investors refocus on earnings resilience, margins and execution quality over short-term themes. We’ll now explore how this softer...

Elsight (ASX:ELS) drew fresh attention after a 3.11% share price move as investors focused on its role providing connectivity solutions for autonomous and remotely operated systems, particularly drones operating beyond the operator’s line of sight. See our latest analysis for Elsight. The 13.38% 7 day share price return and 15.83% 90 day share price return build on Elsight’s strong year to date momentum of 135.38%, while the 1 year total shareholder return above 400% underlines how sentiment...

The recent 38% drop in Clara Resources Australia Ltd's ( ASX:C7A ) stock could come as a blow to insiders who purchased...

Earlier this week, Bank of Queensland released a fresh financial update that has put the Australian lender and its peers under closer market scrutiny as investors reassess the outlook for the banking sector. This update lands at a time when commodity price moves, global earnings releases and shifting monetary policy expectations are all influencing how investors view banks’ earnings resilience and risk profiles. We’ll now explore how Bank of Queensland’s latest financial update interacts...

With inflation expectations tied to oil prices, central banks weighing rate moves and growth signals mixed across major economies, many investors are looking for companies where management is clearly aligned with shareholders and focused on expansion. That is the idea behind the Fast Growing Stocks With High Insider Ownership screener, which highlights businesses that combine growth potential with management teams that hold meaningful stakes in their own stock. This article walks through...

Global markets are wrestling with inflation questions, shifting interest rate paths and fresh energy shocks, which keeps reliable power supply firmly in focus for many investors. Nuclear energy stocks sit at the intersection of energy security and low carbon power, covering everything from uranium producers and enrichment facilities to companies that build and operate nuclear reactors. The Nuclear Energy Stocks screener helps you filter this broad universe into a concentrated set of listed...

The federal government’s review of whether six foreign investors complied with divestment orders in Northern Minerals (ASX:NTU) has sharpened attention on ownership control at the Browns Range heavy rare earths project in Western Australia. See our latest analysis for Northern Minerals. At a share price of A$0.026, Northern Minerals has seen the 1 day share price return fall 13.33%, while the 7 day share price return is up 4.00%, and the 1 year total shareholder return is down 7.14%. This...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Even if it's not a huge purchase, we think it was good to see that Allan Ritchie, the CEO & Executive Chairman of...

Over the last year, a good number of insiders have significantly increased their holdings in Toubani Resources Limited...

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, recently drew increased attention as its copper-based theranostic programs in cancer imaging and therapy progressed through multiple clinical trials. The company’s proprietary Targeted Copper Theranostics platform, spanning indications from prostate cancer to paediatric oncology, has become a focal point for investors watching upcoming clinical and regulatory milestones. With this backdrop, we’ll examine how excitement...

As the Australian market navigates a cautious phase, influenced by global chip rallies and geopolitical developments, investors are keenly watching for opportunities that align with these shifting dynamics. In such an environment, growth companies with high insider ownership can offer unique insights and potential resilience, making them attractive considerations for those seeking to understand the interplay between internal confidence and market performance.